Actinium Pharmaceuticals Inc
ATNM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$46.53M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $46.53 Million |
|---|---|
| Enterprise Value | $11.40 Million |
| Earnings per Share | $-1.09 |
| Beta | 0.02 |
| Outstanding Shares | 31,399,086 |
Return
| Return on Equity | 37.32% |
|---|---|
| Return on Assets | 28.16% |
| Return on Invested Capital | 26.64% |
Valuation & Multiples
| P/E Ratio | 4.11 |
|---|---|
| PEG | -0.81 |
| Price to Sales | 1.43 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.32 |
| Enterprise Value to EBIT | 1.39 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 14, 2026
EPS Estimate
$-0.20
Consensus analyst estimateRevenue Estimate
$35.62 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 13, 2026
EPS Estimate
$-0.25
Consensus analyst estimateRevenue Estimate
$1.25 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.24%▼ 15.61% |
|---|---|
| Total Invested | $435,957▼ 91.59% |
| Investors Holding | 3▼ 45.00% |
About Actinium Pharmaceuticals Inc
CEO: Sandesh Seth
